Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 5
Submit an article Journal homepage
82
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia cells

Cecilia M. RodriguezHospital Nacional de Clínicas, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina; ;Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI-CONICET) Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; View further author information
,
Claudio BussiCentro de Investigación en Bioquímica Clínica e Inmunología (CIBICI-CONICET) Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; View further author information
,
Daniela S. ArroyoHospital Nacional de Clínicas, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina; ;Centro de Investigación en Bioquímica Clínica e Inmunología (CIBICI-CONICET) Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; View further author information
,
Dario SastreHospital Nacional de Clínicas, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina; View further author information
,
Viviana HellerHospital Nacional de Clínicas, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina; View further author information
,
Carmen StanganelliPatología Molecular, Instituto de Investigaciones Hematológicas Academia Nacional de Medicina, Buenos Aires, Argentina; View further author information
,
Irma SlavutskyLaboratorio de Genética de Neoplasias Linfoides, Instituto de Medicina Experimental, CONICET-Academia Nacional de Medicina, Buenos Aires, ArgentinaView further author information
&
Pablo IribarrenCentro de Investigación en Bioquímica Clínica e Inmunología (CIBICI-CONICET) Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina; Correspondence[email protected]
View further author information
 show all
Pages 1299-1303 | Received 11 Mar 2018, Accepted 21 Sep 2018, Published online: 08 Nov 2018

References

  • Bologna C, Buonincontri R, Serra S, et al. SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response. J Clin Invest. 2016;126:181–194.
  • Burger JA, Chiorazzi N. B cell receptor signaling in chronic lymphocytic leukemia. Trends Immunol. 2013;34:592–601.
  • Malavasi F, Deaglio S, Damle R, et al. CD38 and chronic lymphocytic leukemia: a decade later. Blood. 2011;118:3470–3478.
  • Balatti V, Pekarky Y, Croce CM. Role of microRNA in chronic lymphocytic leukemia onset and progression. J Hematol Oncol. 2015;8:12.
  • Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102:13944–13949.
  • Podhorecka M, Klimek P, Chocholska S, et al. The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia. Eur J Clin Pharmacol. 2015;71:1121–1127.
  • Gribben JG, O'Brien S. Update on therapy of chronic lymphocytic leukemia. J Clin Oncol. 2011;29:544–550.
  • Smolewski P. Investigating mammalian target of rapamycin inhibitors for their anticancer properties. Expert Opin Investig Drugs. 2006;15:1201–1227.
  • Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12:1–222.
  • Billard C. Apoptosis inducers in chronic lymphocytic leukemia. Oncotarget. 2014;5:309–325.
  • Rassenti LZ, Jain S, Keating MJ, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood. 2008;112:1923–1930.
  • Ouillette P, Collins R, Shakhan S, et al. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia. Clin Cancer Res. 2011;17:6778–6790.
  • O’Brien SM, Kantarjian HM, Cortes J, et al. Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia. Jco. 2001;19:1414–1420.
  • Aleskog A, Norberg M, Nygren P, et al. Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cells in vitro, as single agent and in drug combination. Leuk Lymphoma. 2008;49:2333–2343.
  • Davids MS, Brown JR. Targeting the B cell receptor pathway in chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53:2362–2370.
  • Del Poeta G, Del Principe MI, Maurillo L, et al. Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. Leuk Lymphoma. 2010;51:95–106.
  • Al-Harbi S, Hill BT, Mazumder S, et al. An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737. Blood. 2011;118:3579–3590.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.